Discrimination Remains "Embedded" In Korea Rx Pricing Reform - PhRMA
Executive Summary
Discriminatory pricing practices toward imported medicines remain "embedded" in Korea's reformed product listing policy for its national health insurance reimbursement schedule, Pharmaceutical Research and Manufacturers of America Senior VP for International Affairs Shannon Hertzfeld told a press briefing July 26.